Wu Capital has led a series A round for Korro Bio, whose RNA editing technology was developed at UChicago-affiliated Marine Biological Laboratory.

Debiopharm Innovation Fund and Crédit Mutuel Innovation co-led an $11.9m round for the digital pain management technology provider.

University of Utah's drug discovery technology producer has raised series D funding to increase its post-money valuation to some $1.2bn.

The drug discovery technology producer received $50m from strategic partner Bayer in the round, which valued it at about $1.2bn post-money.

Illumina's cancer diagnostics spinoff, which has raised more than $1.9bn in funding, has filed to float on the Nasdaq Global Select Market.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The Vietnam-focused venture firm’s maiden fund has attracted commitments from limited partners Naver, Sea and Woowa Brothers on the way to a $50m target.

The $14.6m round was co-led by distribution partner Fosun Pharma and also featured existing investor Baidu Ventures,

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Grifols has acquired its existing portfolio company Alkahest, five years after buying a 45% stake in the Stanford University spinout.